nodes	percent_of_prediction	percent_of_DWPC	metapath
Imiquimod—TLR8—hematopoietic system—stomach cancer	0.0301	0.156	CbGeAlD
Imiquimod—TLR8—lymphoid tissue—stomach cancer	0.0212	0.11	CbGeAlD
Imiquimod—TLR8—bone marrow—stomach cancer	0.0193	0.1	CbGeAlD
Imiquimod—TLR7—hematopoietic system—stomach cancer	0.019	0.0986	CbGeAlD
Imiquimod—TLR8—endocrine gland—stomach cancer	0.0173	0.0899	CbGeAlD
Imiquimod—TLR8—liver—stomach cancer	0.0156	0.081	CbGeAlD
Imiquimod—TLR7—lymphoid tissue—stomach cancer	0.0134	0.0694	CbGeAlD
Imiquimod—TLR8—lymph node—stomach cancer	0.012	0.0621	CbGeAlD
Imiquimod—TLR7—endocrine gland—stomach cancer	0.0109	0.0567	CbGeAlD
Imiquimod—TLR7—liver—stomach cancer	0.00984	0.0511	CbGeAlD
Imiquimod—TLR7—lymph node—stomach cancer	0.00755	0.0392	CbGeAlD
Imiquimod—CYP1A2—hematopoietic system—stomach cancer	0.00342	0.0178	CbGeAlD
Imiquimod—CYP3A4—hematopoietic system—stomach cancer	0.00248	0.0129	CbGeAlD
Imiquimod—CYP1A2—digestive system—stomach cancer	0.00238	0.0124	CbGeAlD
Imiquimod—CYP1A2—endocrine gland—stomach cancer	0.00197	0.0102	CbGeAlD
Imiquimod—CYP1A2—liver—stomach cancer	0.00177	0.0092	CbGeAlD
Imiquimod—CYP3A4—digestive system—stomach cancer	0.00172	0.00894	CbGeAlD
Imiquimod—CYP3A4—endocrine gland—stomach cancer	0.00142	0.00739	CbGeAlD
Imiquimod—CYP3A4—liver—stomach cancer	0.00128	0.00666	CbGeAlD
Imiquimod—TLR7—Innate Immune System—PPP2R1A—stomach cancer	0.000482	0.00183	CbGpPWpGaD
Imiquimod—TLR8—Innate Immune System—IRS2—stomach cancer	0.000482	0.00183	CbGpPWpGaD
Imiquimod—TLR7—Immune System—BIRC2—stomach cancer	0.000473	0.00179	CbGpPWpGaD
Imiquimod—TLR7—Regulation of toll-like receptor signaling pathway—PIK3CA—stomach cancer	0.00047	0.00178	CbGpPWpGaD
Imiquimod—TLR7—Immune System—CTSL—stomach cancer	0.000468	0.00178	CbGpPWpGaD
Imiquimod—CYP1A2—Arachidonic acid metabolism—AKR1C3—stomach cancer	0.000467	0.00177	CbGpPWpGaD
Imiquimod—TLR8—Immune System—IL1RN—stomach cancer	0.000466	0.00177	CbGpPWpGaD
Imiquimod—CYP1A2—Estrogen Receptor Pathway—JUN—stomach cancer	0.000462	0.00175	CbGpPWpGaD
Imiquimod—TLR7—Immune System—MALT1—stomach cancer	0.000456	0.00173	CbGpPWpGaD
Imiquimod—TLR7—Immune System—LGALS3—stomach cancer	0.000453	0.00172	CbGpPWpGaD
Imiquimod—TLR8—Innate Immune System—IL6ST—stomach cancer	0.000443	0.00168	CbGpPWpGaD
Imiquimod—CYP3A4—Farnesoid X Receptor  Pathway—IRS2—stomach cancer	0.000436	0.00165	CbGpPWpGaD
Imiquimod—TLR8—Immune System—CD44—stomach cancer	0.000435	0.00165	CbGpPWpGaD
Imiquimod—TLR7—Innate Immune System—FYN—stomach cancer	0.000425	0.00161	CbGpPWpGaD
Imiquimod—TLR7—Regulation of toll-like receptor signaling pathway—IL6—stomach cancer	0.000416	0.00158	CbGpPWpGaD
Imiquimod—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP2A6—stomach cancer	0.000415	0.00158	CbGpPWpGaD
Imiquimod—TLR7—Toll-Like Receptors Cascades—IL6—stomach cancer	0.000412	0.00156	CbGpPWpGaD
Imiquimod—CYP1A2—Oxidation by Cytochrome P450—CYP2A6—stomach cancer	0.00041	0.00155	CbGpPWpGaD
Imiquimod—TLR8—Immune System—HBEGF—stomach cancer	0.000409	0.00155	CbGpPWpGaD
Imiquimod—CYP1A2—Estrogen Receptor Pathway—STAT3—stomach cancer	0.0004	0.00152	CbGpPWpGaD
Imiquimod—TLR7—Innate Immune System—FGFR2—stomach cancer	0.000399	0.00151	CbGpPWpGaD
Imiquimod—TLR8—Innate Immune System—CASP8—stomach cancer	0.000396	0.0015	CbGpPWpGaD
Imiquimod—TLR8—Innate Immune System—IL6R—stomach cancer	0.000395	0.0015	CbGpPWpGaD
Imiquimod—TLR7—Immune System—IRF1—stomach cancer	0.00038	0.00144	CbGpPWpGaD
Imiquimod—TLR8—Immune System—PPP2R1A—stomach cancer	0.00037	0.0014	CbGpPWpGaD
Imiquimod—TLR7—Innate Immune System—IRS2—stomach cancer	0.000365	0.00139	CbGpPWpGaD
Imiquimod—TLR7—Immune System—IL1RN—stomach cancer	0.000353	0.00134	CbGpPWpGaD
Imiquimod—CYP1A2—Phase 1 - Functionalization of compounds—CYP2A6—stomach cancer	0.000337	0.00128	CbGpPWpGaD
Imiquimod—TLR7—Innate Immune System—IL6ST—stomach cancer	0.000336	0.00127	CbGpPWpGaD
Imiquimod—TLR8—Innate Immune System—ERBB2—stomach cancer	0.00033	0.00125	CbGpPWpGaD
Imiquimod—TLR7—Immune System—CD44—stomach cancer	0.00033	0.00125	CbGpPWpGaD
Imiquimod—TLR8—Immune System—FYN—stomach cancer	0.000326	0.00124	CbGpPWpGaD
Imiquimod—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2A6—stomach cancer	0.00032	0.00122	CbGpPWpGaD
Imiquimod—CYP3A4—Oxidation by Cytochrome P450—CYP2A6—stomach cancer	0.000316	0.0012	CbGpPWpGaD
Imiquimod—TLR7—Immune System—HBEGF—stomach cancer	0.00031	0.00118	CbGpPWpGaD
Imiquimod—CYP1A2—Phase II conjugation—GSTT1—stomach cancer	0.000309	0.00117	CbGpPWpGaD
Imiquimod—TLR8—Immune System—FGFR2—stomach cancer	0.000306	0.00116	CbGpPWpGaD
Imiquimod—TLR8—Innate Immune System—CDKN1B—stomach cancer	0.000306	0.00116	CbGpPWpGaD
Imiquimod—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—stomach cancer	0.000302	0.00115	CbGpPWpGaD
Imiquimod—Skin disorder—Capecitabine—stomach cancer	0.000302	0.000555	CcSEcCtD
Imiquimod—Urinary tract disorder—Epirubicin—stomach cancer	0.000301	0.000553	CcSEcCtD
Imiquimod—TLR7—Innate Immune System—CASP8—stomach cancer	0.0003	0.00114	CbGpPWpGaD
Imiquimod—Hyperhidrosis—Capecitabine—stomach cancer	0.0003	0.000552	CcSEcCtD
Imiquimod—TLR7—Innate Immune System—IL6R—stomach cancer	0.000299	0.00114	CbGpPWpGaD
Imiquimod—Connective tissue disorder—Epirubicin—stomach cancer	0.000299	0.000551	CcSEcCtD
Imiquimod—Urethral disorder—Epirubicin—stomach cancer	0.000299	0.000549	CcSEcCtD
Imiquimod—Hepatobiliary disease—Doxorubicin—stomach cancer	0.000297	0.000546	CcSEcCtD
Imiquimod—Anorexia—Capecitabine—stomach cancer	0.000296	0.000545	CcSEcCtD
Imiquimod—Angiopathy—Methotrexate—stomach cancer	0.000295	0.000543	CcSEcCtD
Imiquimod—Vomiting—Irinotecan—stomach cancer	0.000295	0.000543	CcSEcCtD
Imiquimod—Sinusitis—Doxorubicin—stomach cancer	0.000295	0.000542	CcSEcCtD
Imiquimod—Immune system disorder—Methotrexate—stomach cancer	0.000294	0.000541	CcSEcCtD
Imiquimod—Dizziness—Fluorouracil—stomach cancer	0.000294	0.000541	CcSEcCtD
Imiquimod—Visual impairment—Epirubicin—stomach cancer	0.000294	0.00054	CcSEcCtD
Imiquimod—Mediastinal disorder—Methotrexate—stomach cancer	0.000293	0.00054	CcSEcCtD
Imiquimod—Rash—Irinotecan—stomach cancer	0.000293	0.000538	CcSEcCtD
Imiquimod—Dermatitis—Irinotecan—stomach cancer	0.000292	0.000538	CcSEcCtD
Imiquimod—Musculoskeletal discomfort—Docetaxel—stomach cancer	0.000292	0.000538	CcSEcCtD
Imiquimod—Chills—Methotrexate—stomach cancer	0.000292	0.000537	CcSEcCtD
Imiquimod—TLR8—Innate Immune System—JUN—stomach cancer	0.000291	0.00111	CbGpPWpGaD
Imiquimod—Headache—Irinotecan—stomach cancer	0.000291	0.000535	CcSEcCtD
Imiquimod—Insomnia—Docetaxel—stomach cancer	0.00029	0.000534	CcSEcCtD
Imiquimod—Paraesthesia—Docetaxel—stomach cancer	0.000288	0.00053	CcSEcCtD
Imiquimod—Erythema multiforme—Epirubicin—stomach cancer	0.000288	0.00053	CcSEcCtD
Imiquimod—Alopecia—Methotrexate—stomach cancer	0.000288	0.000529	CcSEcCtD
Imiquimod—Dyspnoea—Docetaxel—stomach cancer	0.000286	0.000526	CcSEcCtD
Imiquimod—Somnolence—Docetaxel—stomach cancer	0.000285	0.000525	CcSEcCtD
Imiquimod—Mental disorder—Methotrexate—stomach cancer	0.000285	0.000524	CcSEcCtD
Imiquimod—Eye disorder—Epirubicin—stomach cancer	0.000285	0.000524	CcSEcCtD
Imiquimod—Tinnitus—Epirubicin—stomach cancer	0.000284	0.000522	CcSEcCtD
Imiquimod—Malnutrition—Methotrexate—stomach cancer	0.000283	0.000521	CcSEcCtD
Imiquimod—Erythema—Methotrexate—stomach cancer	0.000283	0.000521	CcSEcCtD
Imiquimod—Haemoglobin—Doxorubicin—stomach cancer	0.000283	0.000521	CcSEcCtD
Imiquimod—Musculoskeletal discomfort—Capecitabine—stomach cancer	0.000283	0.000521	CcSEcCtD
Imiquimod—Flushing—Epirubicin—stomach cancer	0.000283	0.00052	CcSEcCtD
Imiquimod—Vomiting—Fluorouracil—stomach cancer	0.000283	0.00052	CcSEcCtD
Imiquimod—Rhinitis—Doxorubicin—stomach cancer	0.000283	0.00052	CcSEcCtD
Imiquimod—Dyspepsia—Docetaxel—stomach cancer	0.000282	0.000519	CcSEcCtD
Imiquimod—TLR8—Innate Immune System—CDKN1A—stomach cancer	0.000282	0.00107	CbGpPWpGaD
Imiquimod—Haemorrhage—Doxorubicin—stomach cancer	0.000282	0.000518	CcSEcCtD
Imiquimod—Insomnia—Capecitabine—stomach cancer	0.000281	0.000517	CcSEcCtD
Imiquimod—TLR7—Immune System—PPP2R1A—stomach cancer	0.000281	0.00106	CbGpPWpGaD
Imiquimod—TLR8—Immune System—IRS2—stomach cancer	0.000281	0.00106	CbGpPWpGaD
Imiquimod—Rash—Fluorouracil—stomach cancer	0.00028	0.000515	CcSEcCtD
Imiquimod—Dermatitis—Fluorouracil—stomach cancer	0.00028	0.000515	CcSEcCtD
Imiquimod—Pharyngitis—Doxorubicin—stomach cancer	0.00028	0.000514	CcSEcCtD
Imiquimod—Paraesthesia—Capecitabine—stomach cancer	0.000279	0.000513	CcSEcCtD
Imiquimod—Decreased appetite—Docetaxel—stomach cancer	0.000279	0.000513	CcSEcCtD
Imiquimod—Headache—Fluorouracil—stomach cancer	0.000279	0.000512	CcSEcCtD
Imiquimod—Urinary tract disorder—Doxorubicin—stomach cancer	0.000278	0.000512	CcSEcCtD
Imiquimod—Gastrointestinal disorder—Docetaxel—stomach cancer	0.000277	0.000509	CcSEcCtD
Imiquimod—Connective tissue disorder—Doxorubicin—stomach cancer	0.000277	0.000509	CcSEcCtD
Imiquimod—Dyspnoea—Capecitabine—stomach cancer	0.000277	0.000509	CcSEcCtD
Imiquimod—Fatigue—Docetaxel—stomach cancer	0.000277	0.000509	CcSEcCtD
Imiquimod—Angiopathy—Epirubicin—stomach cancer	0.000276	0.000508	CcSEcCtD
Imiquimod—Urethral disorder—Doxorubicin—stomach cancer	0.000276	0.000508	CcSEcCtD
Imiquimod—Nausea—Irinotecan—stomach cancer	0.000276	0.000507	CcSEcCtD
Imiquimod—TLR8—Innate Immune System—MAPK8—stomach cancer	0.000276	0.00105	CbGpPWpGaD
Imiquimod—Immune system disorder—Epirubicin—stomach cancer	0.000275	0.000506	CcSEcCtD
Imiquimod—Mediastinal disorder—Epirubicin—stomach cancer	0.000275	0.000505	CcSEcCtD
Imiquimod—Pain—Docetaxel—stomach cancer	0.000274	0.000505	CcSEcCtD
Imiquimod—Back pain—Methotrexate—stomach cancer	0.000274	0.000504	CcSEcCtD
Imiquimod—Dyspepsia—Capecitabine—stomach cancer	0.000273	0.000503	CcSEcCtD
Imiquimod—Chills—Epirubicin—stomach cancer	0.000273	0.000503	CcSEcCtD
Imiquimod—Arrhythmia—Epirubicin—stomach cancer	0.000272	0.0005	CcSEcCtD
Imiquimod—Visual impairment—Doxorubicin—stomach cancer	0.000272	0.0005	CcSEcCtD
Imiquimod—Decreased appetite—Capecitabine—stomach cancer	0.00027	0.000497	CcSEcCtD
Imiquimod—Alopecia—Epirubicin—stomach cancer	0.000269	0.000495	CcSEcCtD
Imiquimod—Gastrointestinal disorder—Capecitabine—stomach cancer	0.000268	0.000493	CcSEcCtD
Imiquimod—Fatigue—Capecitabine—stomach cancer	0.000268	0.000493	CcSEcCtD
Imiquimod—Mental disorder—Epirubicin—stomach cancer	0.000267	0.000491	CcSEcCtD
Imiquimod—Erythema multiforme—Doxorubicin—stomach cancer	0.000267	0.00049	CcSEcCtD
Imiquimod—Pain—Capecitabine—stomach cancer	0.000266	0.000489	CcSEcCtD
Imiquimod—Malnutrition—Epirubicin—stomach cancer	0.000265	0.000488	CcSEcCtD
Imiquimod—Erythema—Epirubicin—stomach cancer	0.000265	0.000488	CcSEcCtD
Imiquimod—Feeling abnormal—Docetaxel—stomach cancer	0.000264	0.000486	CcSEcCtD
Imiquimod—Nausea—Fluorouracil—stomach cancer	0.000264	0.000486	CcSEcCtD
Imiquimod—Eye disorder—Doxorubicin—stomach cancer	0.000263	0.000484	CcSEcCtD
Imiquimod—Ill-defined disorder—Methotrexate—stomach cancer	0.000263	0.000484	CcSEcCtD
Imiquimod—Tinnitus—Doxorubicin—stomach cancer	0.000263	0.000483	CcSEcCtD
Imiquimod—Gastrointestinal pain—Docetaxel—stomach cancer	0.000262	0.000483	CcSEcCtD
Imiquimod—Flushing—Doxorubicin—stomach cancer	0.000262	0.000481	CcSEcCtD
Imiquimod—CYP3A4—Phase 1 - Functionalization of compounds—CYP2A6—stomach cancer	0.00026	0.000985	CbGpPWpGaD
Imiquimod—TLR8—Immune System—PRKCB—stomach cancer	0.000259	0.000983	CbGpPWpGaD
Imiquimod—TLR8—Immune System—IL6ST—stomach cancer	0.000258	0.000979	CbGpPWpGaD
Imiquimod—Back pain—Epirubicin—stomach cancer	0.000257	0.000472	CcSEcCtD
Imiquimod—Feeling abnormal—Capecitabine—stomach cancer	0.000256	0.000471	CcSEcCtD
Imiquimod—Angiopathy—Doxorubicin—stomach cancer	0.000256	0.00047	CcSEcCtD
Imiquimod—Malaise—Methotrexate—stomach cancer	0.000256	0.00047	CcSEcCtD
Imiquimod—Immune system disorder—Doxorubicin—stomach cancer	0.000255	0.000468	CcSEcCtD
Imiquimod—Gastrointestinal pain—Capecitabine—stomach cancer	0.000254	0.000467	CcSEcCtD
Imiquimod—Mediastinal disorder—Doxorubicin—stomach cancer	0.000254	0.000467	CcSEcCtD
Imiquimod—Abdominal pain—Docetaxel—stomach cancer	0.000254	0.000466	CcSEcCtD
Imiquimod—Body temperature increased—Docetaxel—stomach cancer	0.000254	0.000466	CcSEcCtD
Imiquimod—Chills—Doxorubicin—stomach cancer	0.000253	0.000465	CcSEcCtD
Imiquimod—Arrhythmia—Doxorubicin—stomach cancer	0.000252	0.000463	CcSEcCtD
Imiquimod—TLR7—Innate Immune System—ERBB2—stomach cancer	0.00025	0.00095	CbGpPWpGaD
Imiquimod—Alopecia—Doxorubicin—stomach cancer	0.000249	0.000458	CcSEcCtD
Imiquimod—TLR7—Immune System—FYN—stomach cancer	0.000247	0.000939	CbGpPWpGaD
Imiquimod—Cough—Methotrexate—stomach cancer	0.000247	0.000455	CcSEcCtD
Imiquimod—Mental disorder—Doxorubicin—stomach cancer	0.000247	0.000454	CcSEcCtD
Imiquimod—Urticaria—Capecitabine—stomach cancer	0.000247	0.000454	CcSEcCtD
Imiquimod—Ill-defined disorder—Epirubicin—stomach cancer	0.000246	0.000452	CcSEcCtD
Imiquimod—Abdominal pain—Capecitabine—stomach cancer	0.000246	0.000452	CcSEcCtD
Imiquimod—Body temperature increased—Capecitabine—stomach cancer	0.000246	0.000452	CcSEcCtD
Imiquimod—Convulsion—Methotrexate—stomach cancer	0.000246	0.000452	CcSEcCtD
Imiquimod—Erythema—Doxorubicin—stomach cancer	0.000245	0.000451	CcSEcCtD
Imiquimod—Malnutrition—Doxorubicin—stomach cancer	0.000245	0.000451	CcSEcCtD
Imiquimod—Agitation—Epirubicin—stomach cancer	0.000244	0.000448	CcSEcCtD
Imiquimod—Myalgia—Methotrexate—stomach cancer	0.000241	0.000444	CcSEcCtD
Imiquimod—Arthralgia—Methotrexate—stomach cancer	0.000241	0.000444	CcSEcCtD
Imiquimod—Chest pain—Methotrexate—stomach cancer	0.000241	0.000444	CcSEcCtD
Imiquimod—TLR8—Innate Immune System—MAPK3—stomach cancer	0.000241	0.000913	CbGpPWpGaD
Imiquimod—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—stomach cancer	0.00024	0.000441	CcSEcCtD
Imiquimod—Malaise—Epirubicin—stomach cancer	0.000239	0.00044	CcSEcCtD
Imiquimod—Discomfort—Methotrexate—stomach cancer	0.000238	0.000438	CcSEcCtD
Imiquimod—Syncope—Epirubicin—stomach cancer	0.000238	0.000437	CcSEcCtD
Imiquimod—Back pain—Doxorubicin—stomach cancer	0.000237	0.000436	CcSEcCtD
Imiquimod—Hypersensitivity—Docetaxel—stomach cancer	0.000236	0.000435	CcSEcCtD
Imiquimod—Palpitations—Epirubicin—stomach cancer	0.000234	0.000431	CcSEcCtD
Imiquimod—Loss of consciousness—Epirubicin—stomach cancer	0.000233	0.000429	CcSEcCtD
Imiquimod—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—stomach cancer	0.000233	0.000884	CbGpPWpGaD
Imiquimod—TLR7—Immune System—FGFR2—stomach cancer	0.000232	0.000881	CbGpPWpGaD
Imiquimod—TLR7—Innate Immune System—CDKN1B—stomach cancer	0.000232	0.00088	CbGpPWpGaD
Imiquimod—Cough—Epirubicin—stomach cancer	0.000231	0.000426	CcSEcCtD
Imiquimod—TLR8—Immune System—CASP8—stomach cancer	0.000231	0.000876	CbGpPWpGaD
Imiquimod—Asthenia—Docetaxel—stomach cancer	0.00023	0.000423	CcSEcCtD
Imiquimod—TLR8—Immune System—IL6R—stomach cancer	0.00023	0.000873	CbGpPWpGaD
Imiquimod—Convulsion—Epirubicin—stomach cancer	0.00023	0.000423	CcSEcCtD
Imiquimod—Infection—Methotrexate—stomach cancer	0.00023	0.000423	CcSEcCtD
Imiquimod—TLR8—Innate Immune System—MAPK1—stomach cancer	0.000229	0.000869	CbGpPWpGaD
Imiquimod—TLR8—Innate Immune System—EGFR—stomach cancer	0.000229	0.000869	CbGpPWpGaD
Imiquimod—Hypertension—Epirubicin—stomach cancer	0.000229	0.000421	CcSEcCtD
Imiquimod—Hypersensitivity—Capecitabine—stomach cancer	0.000229	0.000421	CcSEcCtD
Imiquimod—TLR8—Immune System—CDH1—stomach cancer	0.000228	0.000865	CbGpPWpGaD
Imiquimod—Ill-defined disorder—Doxorubicin—stomach cancer	0.000228	0.000419	CcSEcCtD
Imiquimod—Pruritus—Docetaxel—stomach cancer	0.000227	0.000417	CcSEcCtD
Imiquimod—Nervous system disorder—Methotrexate—stomach cancer	0.000227	0.000417	CcSEcCtD
Imiquimod—Chest pain—Epirubicin—stomach cancer	0.000226	0.000415	CcSEcCtD
Imiquimod—Arthralgia—Epirubicin—stomach cancer	0.000226	0.000415	CcSEcCtD
Imiquimod—Myalgia—Epirubicin—stomach cancer	0.000226	0.000415	CcSEcCtD
Imiquimod—Agitation—Doxorubicin—stomach cancer	0.000225	0.000415	CcSEcCtD
Imiquimod—Anxiety—Epirubicin—stomach cancer	0.000225	0.000414	CcSEcCtD
Imiquimod—Skin disorder—Methotrexate—stomach cancer	0.000225	0.000413	CcSEcCtD
Imiquimod—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—stomach cancer	0.000224	0.000412	CcSEcCtD
Imiquimod—Hyperhidrosis—Methotrexate—stomach cancer	0.000224	0.000411	CcSEcCtD
Imiquimod—Discomfort—Epirubicin—stomach cancer	0.000223	0.00041	CcSEcCtD
Imiquimod—Asthenia—Capecitabine—stomach cancer	0.000223	0.00041	CcSEcCtD
Imiquimod—Malaise—Doxorubicin—stomach cancer	0.000221	0.000407	CcSEcCtD
Imiquimod—Dry mouth—Epirubicin—stomach cancer	0.000221	0.000406	CcSEcCtD
Imiquimod—TLR7—Innate Immune System—JUN—stomach cancer	0.000221	0.000838	CbGpPWpGaD
Imiquimod—Anorexia—Methotrexate—stomach cancer	0.00022	0.000405	CcSEcCtD
Imiquimod—Syncope—Doxorubicin—stomach cancer	0.00022	0.000405	CcSEcCtD
Imiquimod—Pruritus—Capecitabine—stomach cancer	0.00022	0.000404	CcSEcCtD
Imiquimod—Diarrhoea—Docetaxel—stomach cancer	0.00022	0.000404	CcSEcCtD
Imiquimod—Palpitations—Doxorubicin—stomach cancer	0.000217	0.000399	CcSEcCtD
Imiquimod—Oedema—Epirubicin—stomach cancer	0.000216	0.000398	CcSEcCtD
Imiquimod—TLR8—Innate Immune System—KRAS—stomach cancer	0.000216	0.000821	CbGpPWpGaD
Imiquimod—Loss of consciousness—Doxorubicin—stomach cancer	0.000216	0.000397	CcSEcCtD
Imiquimod—Infection—Epirubicin—stomach cancer	0.000215	0.000395	CcSEcCtD
Imiquimod—CYP1A2—Phase II conjugation—GSTP1—stomach cancer	0.000214	0.000813	CbGpPWpGaD
Imiquimod—Cough—Doxorubicin—stomach cancer	0.000214	0.000394	CcSEcCtD
Imiquimod—TLR7—Innate Immune System—CDKN1A—stomach cancer	0.000214	0.000812	CbGpPWpGaD
Imiquimod—Shock—Epirubicin—stomach cancer	0.000213	0.000392	CcSEcCtD
Imiquimod—TLR7—Immune System—IRS2—stomach cancer	0.000213	0.000807	CbGpPWpGaD
Imiquimod—Convulsion—Doxorubicin—stomach cancer	0.000213	0.000391	CcSEcCtD
Imiquimod—Diarrhoea—Capecitabine—stomach cancer	0.000213	0.000391	CcSEcCtD
Imiquimod—Nervous system disorder—Epirubicin—stomach cancer	0.000212	0.00039	CcSEcCtD
Imiquimod—Dizziness—Docetaxel—stomach cancer	0.000212	0.00039	CcSEcCtD
Imiquimod—Hypertension—Doxorubicin—stomach cancer	0.000212	0.00039	CcSEcCtD
Imiquimod—Tachycardia—Epirubicin—stomach cancer	0.000211	0.000388	CcSEcCtD
Imiquimod—Musculoskeletal discomfort—Methotrexate—stomach cancer	0.000211	0.000387	CcSEcCtD
Imiquimod—Skin disorder—Epirubicin—stomach cancer	0.00021	0.000387	CcSEcCtD
Imiquimod—Hyperhidrosis—Epirubicin—stomach cancer	0.000209	0.000385	CcSEcCtD
Imiquimod—Insomnia—Methotrexate—stomach cancer	0.000209	0.000385	CcSEcCtD
Imiquimod—Chest pain—Doxorubicin—stomach cancer	0.000209	0.000384	CcSEcCtD
Imiquimod—Arthralgia—Doxorubicin—stomach cancer	0.000209	0.000384	CcSEcCtD
Imiquimod—Myalgia—Doxorubicin—stomach cancer	0.000209	0.000384	CcSEcCtD
Imiquimod—TLR7—Innate Immune System—MAPK8—stomach cancer	0.000209	0.000792	CbGpPWpGaD
Imiquimod—Anxiety—Doxorubicin—stomach cancer	0.000208	0.000383	CcSEcCtD
Imiquimod—Paraesthesia—Methotrexate—stomach cancer	0.000208	0.000382	CcSEcCtD
Imiquimod—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—stomach cancer	0.000207	0.000382	CcSEcCtD
Imiquimod—Discomfort—Doxorubicin—stomach cancer	0.000206	0.00038	CcSEcCtD
Imiquimod—Anorexia—Epirubicin—stomach cancer	0.000206	0.000379	CcSEcCtD
Imiquimod—Dyspnoea—Methotrexate—stomach cancer	0.000206	0.000379	CcSEcCtD
Imiquimod—Somnolence—Methotrexate—stomach cancer	0.000206	0.000378	CcSEcCtD
Imiquimod—Dizziness—Capecitabine—stomach cancer	0.000205	0.000378	CcSEcCtD
Imiquimod—Dry mouth—Doxorubicin—stomach cancer	0.000204	0.000376	CcSEcCtD
Imiquimod—Vomiting—Docetaxel—stomach cancer	0.000204	0.000375	CcSEcCtD
Imiquimod—Dyspepsia—Methotrexate—stomach cancer	0.000204	0.000374	CcSEcCtD
Imiquimod—Rash—Docetaxel—stomach cancer	0.000202	0.000372	CcSEcCtD
Imiquimod—Dermatitis—Docetaxel—stomach cancer	0.000202	0.000372	CcSEcCtD
Imiquimod—Decreased appetite—Methotrexate—stomach cancer	0.000201	0.00037	CcSEcCtD
Imiquimod—Headache—Docetaxel—stomach cancer	0.000201	0.00037	CcSEcCtD
Imiquimod—Oedema—Doxorubicin—stomach cancer	0.0002	0.000368	CcSEcCtD
Imiquimod—Gastrointestinal disorder—Methotrexate—stomach cancer	0.0002	0.000367	CcSEcCtD
Imiquimod—Fatigue—Methotrexate—stomach cancer	0.000199	0.000367	CcSEcCtD
Imiquimod—Infection—Doxorubicin—stomach cancer	0.000199	0.000366	CcSEcCtD
Imiquimod—TLR8—Innate Immune System—PIK3CA—stomach cancer	0.000199	0.000754	CbGpPWpGaD
Imiquimod—Pain—Methotrexate—stomach cancer	0.000198	0.000364	CcSEcCtD
Imiquimod—Vomiting—Capecitabine—stomach cancer	0.000198	0.000363	CcSEcCtD
Imiquimod—Musculoskeletal discomfort—Epirubicin—stomach cancer	0.000197	0.000363	CcSEcCtD
Imiquimod—Shock—Doxorubicin—stomach cancer	0.000197	0.000362	CcSEcCtD
Imiquimod—CYP1A2—Phase II conjugation—GSTM1—stomach cancer	0.000197	0.000747	CbGpPWpGaD
Imiquimod—Nervous system disorder—Doxorubicin—stomach cancer	0.000196	0.000361	CcSEcCtD
Imiquimod—TLR7—Immune System—PRKCB—stomach cancer	0.000196	0.000745	CbGpPWpGaD
Imiquimod—Rash—Capecitabine—stomach cancer	0.000196	0.00036	CcSEcCtD
Imiquimod—Insomnia—Epirubicin—stomach cancer	0.000196	0.00036	CcSEcCtD
Imiquimod—Dermatitis—Capecitabine—stomach cancer	0.000196	0.00036	CcSEcCtD
Imiquimod—TLR7—Immune System—IL6ST—stomach cancer	0.000195	0.000742	CbGpPWpGaD
Imiquimod—Tachycardia—Doxorubicin—stomach cancer	0.000195	0.000359	CcSEcCtD
Imiquimod—Headache—Capecitabine—stomach cancer	0.000195	0.000358	CcSEcCtD
Imiquimod—Skin disorder—Doxorubicin—stomach cancer	0.000195	0.000358	CcSEcCtD
Imiquimod—Paraesthesia—Epirubicin—stomach cancer	0.000194	0.000357	CcSEcCtD
Imiquimod—Hyperhidrosis—Doxorubicin—stomach cancer	0.000194	0.000356	CcSEcCtD
Imiquimod—Dyspnoea—Epirubicin—stomach cancer	0.000193	0.000355	CcSEcCtD
Imiquimod—TLR8—Immune System—ERBB2—stomach cancer	0.000192	0.00073	CbGpPWpGaD
Imiquimod—Somnolence—Epirubicin—stomach cancer	0.000192	0.000354	CcSEcCtD
Imiquimod—Anorexia—Doxorubicin—stomach cancer	0.000191	0.000351	CcSEcCtD
Imiquimod—Nausea—Docetaxel—stomach cancer	0.000191	0.000351	CcSEcCtD
Imiquimod—Feeling abnormal—Methotrexate—stomach cancer	0.000191	0.00035	CcSEcCtD
Imiquimod—Dyspepsia—Epirubicin—stomach cancer	0.000191	0.00035	CcSEcCtD
Imiquimod—Gastrointestinal pain—Methotrexate—stomach cancer	0.000189	0.000348	CcSEcCtD
Imiquimod—Decreased appetite—Epirubicin—stomach cancer	0.000188	0.000346	CcSEcCtD
Imiquimod—Gastrointestinal disorder—Epirubicin—stomach cancer	0.000187	0.000344	CcSEcCtD
Imiquimod—Fatigue—Epirubicin—stomach cancer	0.000187	0.000343	CcSEcCtD
Imiquimod—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—stomach cancer	0.000187	0.000708	CbGpPWpGaD
Imiquimod—Pain—Epirubicin—stomach cancer	0.000185	0.00034	CcSEcCtD
Imiquimod—Nausea—Capecitabine—stomach cancer	0.000185	0.000339	CcSEcCtD
Imiquimod—TLR8—Innate Immune System—HRAS—stomach cancer	0.000184	0.000698	CbGpPWpGaD
Imiquimod—Urticaria—Methotrexate—stomach cancer	0.000184	0.000338	CcSEcCtD
Imiquimod—Body temperature increased—Methotrexate—stomach cancer	0.000183	0.000336	CcSEcCtD
Imiquimod—Abdominal pain—Methotrexate—stomach cancer	0.000183	0.000336	CcSEcCtD
Imiquimod—Musculoskeletal discomfort—Doxorubicin—stomach cancer	0.000182	0.000336	CcSEcCtD
Imiquimod—TLR7—Innate Immune System—MAPK3—stomach cancer	0.000182	0.000692	CbGpPWpGaD
Imiquimod—Insomnia—Doxorubicin—stomach cancer	0.000181	0.000333	CcSEcCtD
Imiquimod—CYP1A2—Biological oxidations—GSTT1—stomach cancer	0.000181	0.000686	CbGpPWpGaD
Imiquimod—Paraesthesia—Doxorubicin—stomach cancer	0.00018	0.000331	CcSEcCtD
Imiquimod—CYP1A2—Biological oxidations—CYP2A6—stomach cancer	0.000179	0.000678	CbGpPWpGaD
Imiquimod—Dyspnoea—Doxorubicin—stomach cancer	0.000179	0.000328	CcSEcCtD
Imiquimod—Feeling abnormal—Epirubicin—stomach cancer	0.000178	0.000328	CcSEcCtD
Imiquimod—TLR8—Immune System—CDKN1B—stomach cancer	0.000178	0.000676	CbGpPWpGaD
Imiquimod—Somnolence—Doxorubicin—stomach cancer	0.000178	0.000327	CcSEcCtD
Imiquimod—Gastrointestinal pain—Epirubicin—stomach cancer	0.000177	0.000325	CcSEcCtD
Imiquimod—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1B—stomach cancer	0.000177	0.00067	CbGpPWpGaD
Imiquimod—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CDKN1B—stomach cancer	0.000177	0.00067	CbGpPWpGaD
Imiquimod—Dyspepsia—Doxorubicin—stomach cancer	0.000176	0.000324	CcSEcCtD
Imiquimod—TLR8—Innate Immune System—IL6—stomach cancer	0.000176	0.000668	CbGpPWpGaD
Imiquimod—TLR8—Immune System—IL1B—stomach cancer	0.000175	0.000664	CbGpPWpGaD
Imiquimod—TLR7—Immune System—CASP8—stomach cancer	0.000175	0.000664	CbGpPWpGaD
Imiquimod—CYP1A2—Arachidonic acid metabolism—PTGS2—stomach cancer	0.000174	0.000662	CbGpPWpGaD
Imiquimod—TLR7—Immune System—IL6R—stomach cancer	0.000174	0.000662	CbGpPWpGaD
Imiquimod—Decreased appetite—Doxorubicin—stomach cancer	0.000174	0.00032	CcSEcCtD
Imiquimod—TLR7—Innate Immune System—MAPK1—stomach cancer	0.000174	0.000659	CbGpPWpGaD
Imiquimod—TLR7—Innate Immune System—EGFR—stomach cancer	0.000174	0.000658	CbGpPWpGaD
Imiquimod—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—stomach cancer	0.000174	0.000658	CbGpPWpGaD
Imiquimod—Gastrointestinal disorder—Doxorubicin—stomach cancer	0.000173	0.000318	CcSEcCtD
Imiquimod—TLR7—Immune System—CDH1—stomach cancer	0.000173	0.000656	CbGpPWpGaD
Imiquimod—Fatigue—Doxorubicin—stomach cancer	0.000173	0.000318	CcSEcCtD
Imiquimod—Urticaria—Epirubicin—stomach cancer	0.000172	0.000316	CcSEcCtD
Imiquimod—CYP1A2—Metapathway biotransformation—AKR1C3—stomach cancer	0.000172	0.000651	CbGpPWpGaD
Imiquimod—Pain—Doxorubicin—stomach cancer	0.000171	0.000315	CcSEcCtD
Imiquimod—Abdominal pain—Epirubicin—stomach cancer	0.000171	0.000315	CcSEcCtD
Imiquimod—Body temperature increased—Epirubicin—stomach cancer	0.000171	0.000315	CcSEcCtD
Imiquimod—Hypersensitivity—Methotrexate—stomach cancer	0.00017	0.000313	CcSEcCtD
Imiquimod—TLR8—Immune System—JUN—stomach cancer	0.00017	0.000644	CbGpPWpGaD
Imiquimod—CYP1A2—Aryl Hydrocarbon Receptor Pathway—JUN—stomach cancer	0.000168	0.000638	CbGpPWpGaD
Imiquimod—Asthenia—Methotrexate—stomach cancer	0.000166	0.000305	CcSEcCtD
Imiquimod—Feeling abnormal—Doxorubicin—stomach cancer	0.000165	0.000303	CcSEcCtD
Imiquimod—TLR8—Immune System—CDKN1A—stomach cancer	0.000164	0.000624	CbGpPWpGaD
Imiquimod—TLR7—Innate Immune System—KRAS—stomach cancer	0.000164	0.000622	CbGpPWpGaD
Imiquimod—Gastrointestinal pain—Doxorubicin—stomach cancer	0.000164	0.000301	CcSEcCtD
Imiquimod—Pruritus—Methotrexate—stomach cancer	0.000164	0.000301	CcSEcCtD
Imiquimod—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1A—stomach cancer	0.000163	0.000619	CbGpPWpGaD
Imiquimod—TLR8—Immune System—MAPK8—stomach cancer	0.000161	0.000609	CbGpPWpGaD
Imiquimod—Hypersensitivity—Epirubicin—stomach cancer	0.000159	0.000293	CcSEcCtD
Imiquimod—Urticaria—Doxorubicin—stomach cancer	0.000159	0.000293	CcSEcCtD
Imiquimod—Body temperature increased—Doxorubicin—stomach cancer	0.000158	0.000291	CcSEcCtD
Imiquimod—Abdominal pain—Doxorubicin—stomach cancer	0.000158	0.000291	CcSEcCtD
Imiquimod—Diarrhoea—Methotrexate—stomach cancer	0.000158	0.000291	CcSEcCtD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—PPAP2A—stomach cancer	0.000156	0.000592	CbGpPWpGaD
Imiquimod—Asthenia—Epirubicin—stomach cancer	0.000155	0.000286	CcSEcCtD
Imiquimod—Pruritus—Epirubicin—stomach cancer	0.000153	0.000282	CcSEcCtD
Imiquimod—Dizziness—Methotrexate—stomach cancer	0.000153	0.000281	CcSEcCtD
Imiquimod—TLR7—Innate Immune System—PIK3CA—stomach cancer	0.000151	0.000571	CbGpPWpGaD
Imiquimod—Diarrhoea—Epirubicin—stomach cancer	0.000148	0.000272	CcSEcCtD
Imiquimod—Hypersensitivity—Doxorubicin—stomach cancer	0.000148	0.000271	CcSEcCtD
Imiquimod—Vomiting—Methotrexate—stomach cancer	0.000147	0.00027	CcSEcCtD
Imiquimod—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—stomach cancer	0.000147	0.000557	CbGpPWpGaD
Imiquimod—TLR8—Immune System—STAT3—stomach cancer	0.000147	0.000557	CbGpPWpGaD
Imiquimod—TLR7—Immune System—ERBB2—stomach cancer	0.000146	0.000553	CbGpPWpGaD
Imiquimod—Rash—Methotrexate—stomach cancer	0.000146	0.000268	CcSEcCtD
Imiquimod—Dermatitis—Methotrexate—stomach cancer	0.000146	0.000268	CcSEcCtD
Imiquimod—Headache—Methotrexate—stomach cancer	0.000145	0.000266	CcSEcCtD
Imiquimod—Asthenia—Doxorubicin—stomach cancer	0.000144	0.000264	CcSEcCtD
Imiquimod—Dizziness—Epirubicin—stomach cancer	0.000143	0.000263	CcSEcCtD
Imiquimod—Pruritus—Doxorubicin—stomach cancer	0.000142	0.000261	CcSEcCtD
Imiquimod—TLR8—Immune System—MAPK3—stomach cancer	0.00014	0.000532	CbGpPWpGaD
Imiquimod—CYP3A4—Biological oxidations—GSTT1—stomach cancer	0.00014	0.00053	CbGpPWpGaD
Imiquimod—TLR7—Innate Immune System—HRAS—stomach cancer	0.000139	0.000529	CbGpPWpGaD
Imiquimod—CYP3A4—Biological oxidations—CYP2A6—stomach cancer	0.000138	0.000523	CbGpPWpGaD
Imiquimod—Vomiting—Epirubicin—stomach cancer	0.000138	0.000253	CcSEcCtD
Imiquimod—Nausea—Methotrexate—stomach cancer	0.000137	0.000253	CcSEcCtD
Imiquimod—Diarrhoea—Doxorubicin—stomach cancer	0.000137	0.000252	CcSEcCtD
Imiquimod—Rash—Epirubicin—stomach cancer	0.000136	0.000251	CcSEcCtD
Imiquimod—Dermatitis—Epirubicin—stomach cancer	0.000136	0.000251	CcSEcCtD
Imiquimod—Headache—Epirubicin—stomach cancer	0.000136	0.000249	CcSEcCtD
Imiquimod—CYP1A2—Aryl Hydrocarbon Receptor—MYC—stomach cancer	0.000135	0.000513	CbGpPWpGaD
Imiquimod—TLR7—Immune System—CDKN1B—stomach cancer	0.000135	0.000512	CbGpPWpGaD
Imiquimod—TLR8—Immune System—MAPK1—stomach cancer	0.000133	0.000506	CbGpPWpGaD
Imiquimod—TLR7—Innate Immune System—IL6—stomach cancer	0.000133	0.000506	CbGpPWpGaD
Imiquimod—TLR8—Immune System—EGFR—stomach cancer	0.000133	0.000506	CbGpPWpGaD
Imiquimod—TLR7—Immune System—IL1B—stomach cancer	0.000133	0.000503	CbGpPWpGaD
Imiquimod—Dizziness—Doxorubicin—stomach cancer	0.000132	0.000244	CcSEcCtD
Imiquimod—CYP3A4—Metapathway biotransformation—AKR1C3—stomach cancer	0.000132	0.000502	CbGpPWpGaD
Imiquimod—CYP1A2—Aryl Hydrocarbon Receptor—MAPK1—stomach cancer	0.000132	0.000502	CbGpPWpGaD
Imiquimod—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—stomach cancer	0.000132	0.000502	CbGpPWpGaD
Imiquimod—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—stomach cancer	0.000132	0.000502	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—PLIN2—stomach cancer	0.000131	0.000496	CbGpPWpGaD
Imiquimod—TLR7—Immune System—JUN—stomach cancer	0.000129	0.000488	CbGpPWpGaD
Imiquimod—Nausea—Epirubicin—stomach cancer	0.000129	0.000236	CcSEcCtD
Imiquimod—Vomiting—Doxorubicin—stomach cancer	0.000127	0.000234	CcSEcCtD
Imiquimod—Rash—Doxorubicin—stomach cancer	0.000126	0.000232	CcSEcCtD
Imiquimod—Dermatitis—Doxorubicin—stomach cancer	0.000126	0.000232	CcSEcCtD
Imiquimod—TLR8—Immune System—KRAS—stomach cancer	0.000126	0.000478	CbGpPWpGaD
Imiquimod—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—stomach cancer	0.000126	0.000478	CbGpPWpGaD
Imiquimod—CYP1A2—Aryl Hydrocarbon Receptor—TNF—stomach cancer	0.000126	0.000478	CbGpPWpGaD
Imiquimod—Headache—Doxorubicin—stomach cancer	0.000125	0.000231	CcSEcCtD
Imiquimod—CYP1A2—Biological oxidations—GSTP1—stomach cancer	0.000125	0.000476	CbGpPWpGaD
Imiquimod—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—stomach cancer	0.000125	0.000474	CbGpPWpGaD
Imiquimod—TLR7—Immune System—CDKN1A—stomach cancer	0.000125	0.000473	CbGpPWpGaD
Imiquimod—CYP1A2—Metapathway biotransformation—GSTP1—stomach cancer	0.000124	0.000469	CbGpPWpGaD
Imiquimod—TLR7—Immune System—MAPK8—stomach cancer	0.000122	0.000462	CbGpPWpGaD
Imiquimod—Nausea—Doxorubicin—stomach cancer	0.000119	0.000219	CcSEcCtD
Imiquimod—TLR8—Immune System—PIK3CA—stomach cancer	0.000116	0.000439	CbGpPWpGaD
Imiquimod—CYP1A2—Biological oxidations—GSTM1—stomach cancer	0.000115	0.000437	CbGpPWpGaD
Imiquimod—CYP1A2—Metapathway biotransformation—GSTM1—stomach cancer	0.000114	0.000431	CbGpPWpGaD
Imiquimod—TLR7—Immune System—STAT3—stomach cancer	0.000111	0.000422	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—ACAD8—stomach cancer	0.000108	0.000409	CbGpPWpGaD
Imiquimod—TLR8—Immune System—HRAS—stomach cancer	0.000107	0.000406	CbGpPWpGaD
Imiquimod—TLR7—Immune System—MAPK3—stomach cancer	0.000106	0.000403	CbGpPWpGaD
Imiquimod—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—stomach cancer	0.000106	0.000403	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—ECHS1—stomach cancer	0.000105	0.0004	CbGpPWpGaD
Imiquimod—TLR8—Immune System—IL6—stomach cancer	0.000103	0.000389	CbGpPWpGaD
Imiquimod—TLR7—Immune System—MAPK1—stomach cancer	0.000101	0.000384	CbGpPWpGaD
Imiquimod—TLR7—Immune System—EGFR—stomach cancer	0.000101	0.000384	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—FADS1—stomach cancer	9.9e-05	0.000376	CbGpPWpGaD
Imiquimod—CYP3A4—Biological oxidations—GSTP1—stomach cancer	9.67e-05	0.000367	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—GMPR2—stomach cancer	9.61e-05	0.000364	CbGpPWpGaD
Imiquimod—TLR7—Immune System—KRAS—stomach cancer	9.55e-05	0.000362	CbGpPWpGaD
Imiquimod—CYP3A4—Metapathway biotransformation—GSTP1—stomach cancer	9.54e-05	0.000362	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—SREBF2—stomach cancer	9.27e-05	0.000352	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—RORA—stomach cancer	9.16e-05	0.000348	CbGpPWpGaD
Imiquimod—CYP3A4—Biological oxidations—GSTM1—stomach cancer	8.89e-05	0.000337	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—SUCLG1—stomach cancer	8.79e-05	0.000333	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—IDH3B—stomach cancer	8.79e-05	0.000333	CbGpPWpGaD
Imiquimod—TLR7—Immune System—PIK3CA—stomach cancer	8.77e-05	0.000333	CbGpPWpGaD
Imiquimod—CYP3A4—Metapathway biotransformation—GSTM1—stomach cancer	8.77e-05	0.000333	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—ACAD8—stomach cancer	8.32e-05	0.000316	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—NDUFS1—stomach cancer	8.17e-05	0.00031	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—NDUFV1—stomach cancer	8.17e-05	0.00031	CbGpPWpGaD
Imiquimod—TLR7—Immune System—HRAS—stomach cancer	8.12e-05	0.000308	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—ALOX5—stomach cancer	7.98e-05	0.000303	CbGpPWpGaD
Imiquimod—TLR7—Immune System—IL6—stomach cancer	7.77e-05	0.000295	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—GMPR2—stomach cancer	7.41e-05	0.000281	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—BLVRB—stomach cancer	7.28e-05	0.000276	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—PGLS—stomach cancer	7.28e-05	0.000276	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—PPAP2A—stomach cancer	6.95e-05	0.000264	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—SUCLG1—stomach cancer	6.78e-05	0.000257	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—IDH3B—stomach cancer	6.78e-05	0.000257	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C3—stomach cancer	6.68e-05	0.000253	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—NDUFV1—stomach cancer	6.3e-05	0.000239	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—NDUFS1—stomach cancer	6.3e-05	0.000239	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—FBP1—stomach cancer	6.19e-05	0.000235	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—NDUFA2—stomach cancer	6.19e-05	0.000235	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—CKB—stomach cancer	6.19e-05	0.000235	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—CA1—stomach cancer	6.19e-05	0.000235	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—PLIN2—stomach cancer	5.82e-05	0.000221	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—CA2—stomach cancer	5.66e-05	0.000215	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—BLVRB—stomach cancer	5.62e-05	0.000213	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—PGLS—stomach cancer	5.62e-05	0.000213	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—NT5E—stomach cancer	5.52e-05	0.000209	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—PGAM1—stomach cancer	5.52e-05	0.000209	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—PPAP2A—stomach cancer	5.36e-05	0.000203	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—PLCE1—stomach cancer	5.26e-05	0.0002	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—ALDH7A1—stomach cancer	5.26e-05	0.0002	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—UMPS—stomach cancer	5.05e-05	0.000191	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—CA1—stomach cancer	4.78e-05	0.000181	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—FBP1—stomach cancer	4.78e-05	0.000181	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—NDUFA2—stomach cancer	4.78e-05	0.000181	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—CKB—stomach cancer	4.78e-05	0.000181	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—PDHA1—stomach cancer	4.69e-05	0.000178	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—ECHS1—stomach cancer	4.69e-05	0.000178	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—PLIN2—stomach cancer	4.49e-05	0.00017	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—TYMP—stomach cancer	4.41e-05	0.000167	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—FADS1—stomach cancer	4.41e-05	0.000167	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—CA2—stomach cancer	4.37e-05	0.000166	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—NT5E—stomach cancer	4.26e-05	0.000162	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—PGAM1—stomach cancer	4.26e-05	0.000162	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—SREBF2—stomach cancer	4.13e-05	0.000157	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—RORA—stomach cancer	4.08e-05	0.000155	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—PLCE1—stomach cancer	4.06e-05	0.000154	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—ALDH7A1—stomach cancer	4.06e-05	0.000154	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—UMPS—stomach cancer	3.89e-05	0.000148	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—ALDOB—stomach cancer	3.82e-05	0.000145	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—PDHA1—stomach cancer	3.62e-05	0.000137	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—ECHS1—stomach cancer	3.62e-05	0.000137	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—stomach cancer	3.61e-05	0.000137	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—stomach cancer	3.6e-05	0.000137	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—ALOX5—stomach cancer	3.56e-05	0.000135	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—DPYD—stomach cancer	3.5e-05	0.000133	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—FADS1—stomach cancer	3.4e-05	0.000129	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—TYMP—stomach cancer	3.4e-05	0.000129	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—SREBF2—stomach cancer	3.19e-05	0.000121	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—stomach cancer	3.17e-05	0.00012	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—RORA—stomach cancer	3.15e-05	0.00012	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—GSTT1—stomach cancer	3.09e-05	0.000117	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—CYP2A6—stomach cancer	3.06e-05	0.000116	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—AKR1C3—stomach cancer	2.97e-05	0.000113	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—ALDOB—stomach cancer	2.95e-05	0.000112	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—ENO1—stomach cancer	2.9e-05	0.00011	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—ALB—stomach cancer	2.85e-05	0.000108	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—ALOX5—stomach cancer	2.74e-05	0.000104	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—DPYD—stomach cancer	2.7e-05	0.000102	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—CD44—stomach cancer	2.57e-05	9.75e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	2.49e-05	9.46e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—GSTT1—stomach cancer	2.39e-05	9.06e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—CYP2A6—stomach cancer	2.36e-05	8.95e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—AKR1C3—stomach cancer	2.3e-05	8.71e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—ENO1—stomach cancer	2.24e-05	8.49e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—PPP2R1A—stomach cancer	2.19e-05	8.29e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—GSTP1—stomach cancer	2.14e-05	8.13e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—HMOX1—stomach cancer	2.11e-05	8.02e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—TYMS—stomach cancer	1.99e-05	7.56e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—CD44—stomach cancer	1.98e-05	7.53e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—GSTM1—stomach cancer	1.97e-05	7.47e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—ERCC2—stomach cancer	1.85e-05	7.03e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—MTHFR—stomach cancer	1.74e-05	6.61e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—PPP2R1A—stomach cancer	1.69e-05	6.4e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—GSTP1—stomach cancer	1.65e-05	6.28e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—HMOX1—stomach cancer	1.63e-05	6.19e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—CAV1—stomach cancer	1.61e-05	6.09e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—APOA1—stomach cancer	1.6e-05	6.08e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—TYMS—stomach cancer	1.54e-05	5.84e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	1.53e-05	5.82e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—GSTM1—stomach cancer	1.52e-05	5.77e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—ERCC2—stomach cancer	1.43e-05	5.42e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—PPARG—stomach cancer	1.41e-05	5.36e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—MTHFR—stomach cancer	1.34e-05	5.1e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—ALB—stomach cancer	1.27e-05	4.82e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—CAV1—stomach cancer	1.24e-05	4.7e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—APOA1—stomach cancer	1.24e-05	4.69e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—NOS3—stomach cancer	1.21e-05	4.61e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—PTGS2—stomach cancer	1.11e-05	4.21e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—PPARG—stomach cancer	1.09e-05	4.13e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—ALB—stomach cancer	9.8e-06	3.72e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—NOS3—stomach cancer	9.37e-06	3.56e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—PTGS2—stomach cancer	8.57e-06	3.25e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—PIK3CA—stomach cancer	6.83e-06	2.59e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—PIK3CA—stomach cancer	5.27e-06	2e-05	CbGpPWpGaD
